This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Wall Street analysts upgraded Moderna Inc and Evolution Petroleum Corp, and raised Enbridge's price target. Check out analysts' views on MRNA stock.
Stocks · News reference
Jefferies Maintains Hold on Enbridge, Lowers Price Target to C$70
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CIBC Upgrades Enbridge to Outperformer, Raises Price Target to C$78
CIBC analyst Robert Catellier upgrades Enbridge (TSX:ENB) from Neutral to Outperformer and raises the price target from C$77 to C$78.
Enbridge To Acquire Salt Creek Midstream's Crude Oil Gathering Business For $600M In Cash
Enbridge Inc. (Enbridge) (TSX:ENB) (NYSE:ENB) announced today that, through a wholly-owned subsidiary, it has entered into a definitive agreement to acquire Salt Creek Midstream's crude oil gathering business,